Roffman Miller Associates Inc. PA Reduces Stock Holdings in Aflac Incorporated (NYSE:AFL)

Roffman Miller Associates Inc. PA cut its position in shares of Aflac Incorporated (NYSE:AFL) by 0.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 391,464 shares of the financial services provider’s stock after selling 1,442 shares during the period. Aflac makes up 2.7% of Roffman Miller Associates Inc. PA’s holdings, making the stock its 13th biggest holding. Roffman Miller Associates Inc. PA owned 0.07% of Aflac worth $43,766,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of AFL. Sequoia Financial Advisors LLC grew its position in Aflac by 4.1% in the second quarter. Sequoia Financial Advisors LLC now owns 14,138 shares of the financial services provider’s stock worth $1,263,000 after acquiring an additional 560 shares during the period. Wedmont Private Capital grew its holdings in shares of Aflac by 6.3% during the 2nd quarter. Wedmont Private Capital now owns 6,650 shares of the financial services provider’s stock worth $616,000 after purchasing an additional 396 shares during the period. M&G Plc acquired a new stake in shares of Aflac during the 2nd quarter worth about $2,535,000. Foguth Wealth Management LLC. purchased a new stake in Aflac in the 2nd quarter valued at about $224,000. Finally, Smith & Howard Wealth Management LLC acquired a new position in Aflac in the second quarter valued at about $1,222,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Down 0.4 %

AFL stock opened at $107.31 on Monday. The company’s 50 day moving average price is $111.05 and its 200 day moving average price is $102.35. The firm has a market capitalization of $59.61 billion, a price-to-earnings ratio of 16.16, a PEG ratio of 2.05 and a beta of 0.97. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The company had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.84 EPS. On average, equities research analysts anticipate that Aflac Incorporated will post 7.27 EPS for the current fiscal year.

Aflac Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.16%. This is an increase from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date is Wednesday, February 19th. Aflac’s payout ratio is 34.94%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on AFL. Morgan Stanley lifted their price target on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. Piper Sandler boosted their target price on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. UBS Group upped their price target on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. Bank of America lifted their price objective on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Finally, Wells Fargo & Company increased their target price on Aflac to $107.00 and gave the stock a “hold” rating in a research note on Tuesday, December 3rd. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $98.73.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.